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Abstract The ways in which couples communicate about
microbicides is likely to influence microbicide uptake and
usage. We collected quantitative data about whether women
in a microbicide trial discussed microbicides with their part-
ners and explored communication about microbicides during
79 in-depth-interviewswithwomenenrolled in the trial and 17
focus-group discussions with community members. After
4 weeks in the trial, 60 % of 1092 women had discussed
microbicides with their partners; in multivariate analysis, this
was associated with younger age, clinic of enrolment and not
living in households that owned cattle. After 52 weeks, 84 %
of women had discussed microbicides; in multivariate ana-
lysis, this was associated with not living in households that
owned cattle, not living in a household that relied on the
cheapest water source, allocation to 0.5 % PRO2000 gel and
consistent gel adherence.Qualitative findings highlighted that
women in committed relationships were expected to discuss
microbicides with their partners and preferred to use micro-
bicides with their partner’s knowledge. Women had different
reasons for, and ways of, discussing microbicides and these
were influenced by the couple’s decision-making roles.
Although there was tolerance for the use of microbicides
without a partner’s knowledge, the women who used micro-
bicides secretly appeared to be women who were least able to
discuss microbicides. In KwaZulu-Natal, socio-cultural
norms informing sexual communication are amenable to
microbicide introduction.
Keywords Microbicides  Adherence  Communication 
‘Disclosure’  South Africa
Introduction
The CAPRISA 004 trial in South Africa demonstrated that
women assigned to use tenofovir microbicide gel before
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and after sex had a 39 % lower risk of HIV acquisition
when compared to women assigned to use placebo gel [1].
If the on-going FACTS 001 trial confirms the effectiveness
of tenofovir gel, vaginal microbicides will be an important
additional HIV prevention option for women [2]. The fact
that women would be able to use microbicides without
their partner’s knowledge was initially perceived as being
an important feature of microbicides [3]. However,
acceptability research demonstrated that this feature was
less important to women in Africa and Asia than it was to
women in the United States of America (USA) [4–10].
Research in Sub-Saharan Africa has shown that in many
societies women would be expected to discuss microbi-
cides with their partner prior to use. This has been reported
in studies evaluating hypothetical willingness to use mi-
crobicides [11–15], microbicide acceptability based on the
use of surrogate products [16–20], as well as trials evalu-
ating the acceptability of candidate microbicides [5, 21–
23]. The exception is women who engage in sex work who
would not be expected to discuss microbicides with casual
or paying partners [24–27]. Related to this social expec-
tation to discuss microbicides, several of these studies have
also shown that women in committed relationships would
prefer their partners to be aware of their use of microbi-
cides. This preference appears to be driven by the idea that
a couple should not have secrets [28] and a fear of the
ramifications if a man discovered his partner using a
microbicide without prior discussion [5].
Evidence suggests that the discourse ofwomen’s rights and
empowerment that emerged in post-apartheid South Africa
distinguishes expectations of sexual communication in South
Africa from elsewhere on the continent [29]. In South Africa,
there is still an expectation that ideally a couple should discuss
microbicides and there is still a preference among women to
use microbicides with the knowledge of their partner. How-
ever, there appears to be greater tolerance for the use of mi-
crobicides without prior discussion in South Africa than in
other African countries [30–32]. Indeed, a study in both South
Africa and the USA did not find any distinguishable differ-
ences between the countries in attitudes towards using a
microbicide without prior discussion [8].
A number of early microbicide and diaphragm safety and
acceptability studies have reported the number ofwomenwho
have discussed the use of a gel or diaphragm with their part-
ners in Africa. This has ranged from 75 to 98 % among
women and their partners [5, 33–35], 41–50 % among sex
workers and their partners and 0–65 % among sex workers
and their clients [22, 24, 25]. However, data have not yet been
reported on the extent to which women have discussed mi-
crobicides with their partners in later stage trials evaluating
microbicide effectiveness.As such, there has beenno research
to date characterising women according to whether they dis-
cuss the microbicide with their partner or not. Equally,
although it is hypothesised that partner knowledge of micro-
bicides would support adherence, there is limited evidence to
support this to date [35]. In the context of a clinical trial, a
woman’s decision to discuss the gel with a partner is likely to
be influenced by the requirements of participating in a trial,
which involves regular study visits often for a year or more.
Nonetheless, evidence from clinical trials can provide
important information regarding the ways in which women
communicate with partners about the use ofmicrobicides [36,
37].
In this paper, we use quantitative and qualitative data col-
lected as part of the Microbicides Development Programme
MDP 301 clinical trial at the Africa Centre for Health and
Population Studies [38] which is located in the Umkhanyak-
ude district of KwaZulu-Natal, South Africa and was one of
six research centres conducting the MDP 301 clinical trial
[39–41]. The province of KwaZulu-Natal has the highest HIV
prevalence in South Africa at 28 % compared to the national
average of 19 % among 15–49 year olds in 2012 [42].
Nationally, HIV incidence among adults was estimated at 1.7
per 100 person years in 2012, but at 2.63 per 100 person years
in the Africa Centre for Health and Population Studies pop-
ulation based HIV surveillance programme (2004–2011),
peaking at 6.6 per 100 person years in 24 year oldwomen [42,
43]. HIV incidence in theAfricaCentreMDP301 clinical trial
cohort was 3.7 per 100 women years (95 % confidence
interval 2.5, 5.4) [44]. MDP 301 was a randomised, double-
blind, placebo-controlled, phase III clinical trial that evaluated
the safety and efficacy of 0.5 % PRO2000 and 2 % PRO2000
microbicide gel in the prevention of vaginally-acquired HIV
infection. MDP 301 discontinued the evaluation of the 2 %
PRO2000 due to futility in February 2008 on the recom-
mendations of the independent datamonitoring committee. In
December 2009, MDP 301 announced that 0.5 % PRO2000
had not reduced the risk of HIV acquisition among women.
Extensive datawere collected on attitudes tomicrobicides as a
HIV prevention option.
In this paper, using quantitative data, we characterize the
women who do or do not discuss microbicide use with their
partners. Using qualitative data, we examine socio-cultural
norms relating to sexual communication and explore the ways
in which women discuss microbicide gels with their partners.
We explore why and how women use microbicides without
their partner’s knowledge, as well as considering the impli-
cations of these findings for gel adherence.
Methods
Quantitative Methods
The MDP 301 clinical trial has been described in detail
elsewhere [39, 40]. In summary, at enrolment, women were
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randomized to use 2 % PRO2000, 0.5 % PRO2000 or
placebo gel until February 2008 when evaluation of 2 %
PRO2000 was discontinued due to futility, after which time
women were randomised to use 0.5 % PRO2000 or pla-
cebo gel [45]. We asked women to insert a pre-filled
applicator of gel no more than 1 h before each sex act and
to visit the clinics every 4 weeks for 52-weeks.
Cohort
In total, 1,177 women enrolled in the Africa Centre MDP
301 clinical trial from March 2006 to August 2008. We
included 1,092 women in the analysis, after excluding 85
women who didn’t provide data at the week 4 visit. We
enrolled and followed up women at three research clinics:
clinic one was located in a township, clinic two was located
in a small town, and clinic three was located in a rural area
under tribal authority. All three clinics recruited women
from rural areas in addition to the immediate locale of the
clinic.
Dependent Variables
Four weeks after enrolment counsellors administered sex-
ual behaviour questionnaires and collected data about each
sex act in the last week, or the last 4 weeks if a woman had
not had sex in the last week. For each sex act when gel was
used, we asked women the following question: ‘If you used
the gel, did you tell your partner about it?’ For the purpose
of this analysis, we define women as communicating with
their partner about gel use if they informed their partner
about using the gel at any single sex act. The outcome
variable for this quantitative analysis is talking to the
partner about gel use by the week 4 visit. We also assessed
which women communicated with their partners about gel
use by the end of their trial follow-up (which could be up to
52 weeks).
Independent Variables
We considered a range of independent baseline demo-
graphic, study specific and socio-economic variables
including: age, education, employment, relationship to the
head of the household, area of residency, religion, clinic of
enrolment, gel randomization group, participation in pre-
vious MDP studies, household size (measured using the
number of adults who usually sleep in the household
divided by the number of rooms usually used for sleeping),
water source and fuel source used for cooking, as well as
household access to electricity and household ownership of
various assets (cattle, a radio, television, telephone, fridge
and bicycle). We also assessed associations with behav-
ioural variables collected at the week 4 visit including:
sexual activity in the last week, use of reliable contracep-
tion (injectable, oral pill, tubal libation or voluntary sur-
gical contraception), condom and gel use in the last week
or 4 weeks (measured by dividing the total number of
reported sex acts by reported condom or gel use), and
impact of gel on sexual pleasure. In the 52-week analysis,
we also assessed associations with ‘consistent’ gel use,
which was pre-defined in the MDP analysis plan as women
reporting gel use during the last sex act for at least 92 % of
visits attended; return of at least one used applicator to
support their answer when appropriate; and attended at
least seven of the expected 13 visits (unless they became
pregnant or were infected with HIV during follow-up) [40].
Quantitative Analysis
We compared women who reported talking to their part-
ners about gel use by the week 4 visit, to women who did
not. We repeated the analysis comparing women who
reported talking to their partners about the gel anytime
during their participation in the trial, up to a maximum of
52 weeks. We assessed univariate associations using the
Pearson v2 test. We tested the contribution to the multi-
variable model of each variable that was significant in
univariate analysis at the 0.10 level using likelihood ratio
tests (LRT) [46]. We assessed multivariate associations at
the 0.05 level, after controlling for potential confounding
factors, through multiple logistic regression analyses. Data
were analysed using Stata 10 (StataCorp, College Station,
Texas, USA).
Qualitative Methods
Cohort
At enrolment, 101 trial participants were randomly selected
to participate in in-depth interviews (IDIs). Of these, 12
women refused to participate mainly due to the time
commitment, one woman withdrew from the trial before
the first interview, four were never available for interview,
and five were not interviewed around the time of their week
4 visit. Consequently, in this analysis we included inter-
views with 79 trial participants who were interviewed
around the time of their week 4 visit. The interview guide
has been described elsewhere and included the following
topics: partner involvement in decisions relating to sexual
matters and partner involvement in gel use [47].
In addition, we advertised focus group discussions
(FGDs) at community events and conducted them with
women and men who were resident in the trial catchment
area but not enrolled in the trial. Community FGDs were
stratified by sex, age and area of residence. During the
course of the trial 17 standard FGDs were conducted with
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community members, with an average of nine women or
men per group ranging from five to 13. In total six FGDs
were conducted with 54 women and 11 FGDs were con-
ducted with 103 men. We also discussed partner involve-
ment in decisions relating to sexual matters in the
community FGDs.
Demographics of the IDI and FGD respondents are
shown in Table 1.
Qualitative Analysis
We conducted IDIs and FGDs in the local language, isiZ-
ulu. They were audio recorded, transcribed, translated into
English, and imported into NVivo 2, later NVivo 8, for
coding (NVivo qualitative data analysis software; QSR
International Pty Ltd. Version 2, 2002; Version 8, 2008).
The majority of transcripts included both the isiZulu tran-
scription and English translation, although only the English
translation was available for 28 IDIs and four FGDs when
direct audio-translation was used with additional quality
control of the translated text. Coding was conducted in
English. The credibility and trustworthiness of interpreta-
tions were considered throughout the trial by presenting
results of sub-analyses to local staff and members of the
community and participant advisory boards.
We conducted thematic analysis in two stages. Firstly,
we analysed the 17 community FGDs coding all text that
addressed issues relating to sexual communication. Sec-
ondly, we analysed IDIs with 79 women coding all text that
addressed issues relating to sexual communication and
partner involvement in gel use.
Participants provided written informed consent for trial
enrolment. In addition, trial participants and community
members provided written informed consent for participa-
tion in IDIs and FGDs. The University of KwaZulu-Natal
Biomedical Ethics Committee (T111/05) and the South
African Medicine Controls Council (N2/19/8/2) reviewed
and approved the trial protocol.
Results
Quantitative Analysis
Of the 1,092 women included in the analysis, 651 (60 %)
women had discussed gel use with their partners by the
week 4 visit. Of the 651 who discussed gel with their
partners, 578 (89 %) said their partners always knew they
were using the gel while 73 (11 %) said their partners
sometimes knew they were using it. Women who had
discussed gel use with their partners were younger than
women who had not. The relationship between discussing
gel and age was linear (OR 0.986, p value 0.007), although
differences between age groups were not statistically sig-
nificant (p value 0.058) (Table 2).
As shown in Tables 2, 3 and 4, discussing gel use with a
partner was associated at the 10 % level with age (p value
0.058), clinic of enrolment (p value 0.019), water source
(p value 0.026), and household ownership of cattle (p value
0.021). Although associated at the 10 % level, relationship
to the head of household (LRT p = 0.694), previous par-
ticipation in MDP studies (LRT p = 0.270), contraceptive
use (LRT p = 0.251), sexual frequency (LRT p = 0.099)
and condom use (LRT p = 0.177) did not contribute to the
model in likelihood ratio tests so were not included in the
multivariate model. Table 5 presents the output from the
final multivariate model. In the multivariate analysis, older
women (AOR 0.98, p value 0.006), women enrolled at
clinic 1 (AOR 1.00 v clinic 2 at AOR 1.54, p value 0.005)
and women who lived in households that owned cattle
(AOR 0.72, p value 0.021) were significantly less likely to
have discussed gel use with their partners after 4 weeks in
the trial.
Women who enrolled at clinic 1 in the township were
significantly less likely to have discussed gel use with their
partner than women who enrolled at clinic 2 in town. To
explore possible reasons for differences in clinic of enrol-
ment, we created a variable to identify clinic specific
counsellors. In total 13 staff were responsible for gel
adherence counselling in the three clinics during this period
of observation. We created a binary variable to compare
the three main counsellors at clinic 1 to the other 10
counsellors (not presented). When included in the multi-
variate model, there was no longer a difference between
women who discussed gel use with their partners depend-
ing on whether they enrolled at clinic 2 (AOR 1.00 95 %
CI 0.64, 1.56) or clinic 3 (AOR 0.81 95 % CI 0.50, 1.32)
compared to clinic 1. The women counselled by the main
three counsellors at clinic 1 were significantly less likely to
have discussed the gel with their partners than women
counselled by any of the other 10 counsellors at any clinic
(AOR 0.56 95 % CI 0.36, 0.88).
We repeated the analysis comparing women who had
talked to their partners about the gel to women who had
not, any time during their participation in the trial, which
Table 1 Demographics of IDI and FGD participants
Trial IDIs Community
FGDs (female)
Community
FGDs (male)
No of people 79 54 103
No of FGDs – 6 11
Mean age (range) 34 (19–64) 37 (21–63) 30 (17–67)
Employed (%) 18 13 5
Married (%)a 24 41 14
a Marital status was ascertained from the IDI & FGD narratives
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was up to a maximum of 52 weeks. By the end of the trial,
84 % (914/1092) of women in this sample had discussed
the gel with their partners. Based on univariate associa-
tions, the following variables were included in multivariate
analysis: water source, cattle ownership, gel randomisation
group and consistent gel use. By week 52, 73 % of the
women in this sample were defined as consistent gel users.
In this model, women who relied on the cheapest water
source which was free flowing water such as from a river or
stream (AOR 0.53 95 % CI 0.32, 0.89), lived in households
that owned cattle (AOR 0.66 95 % CI 0.47, 0.93), and were
randomised to 2 % PRO2000 (AOR 0.63 95 % CI 0.42,
0.96) or placebo gel (AOR 0.65 95 % CI 0.44, 0.98,
compared to 0.5 % PRO2000) were significantly less likely
to have discussed gel with their partners, and women who
consistently used gel were significantly more likely than
women who had not, to have discussed gel with their
partners (AOR 1.51 95 % CI 1.06, 2.14).
Throughout the course of the trial, 31 women reported
that it was difficult to insert the gel or inconvenient to use it.
In open-ended questions, 12 women reported that the dif-
ficulty or inconvenience was due to the fact that they had
not told their partners about the gel at the time of use. By
week 52, there was a strong association between whether
women had discussed the gel with their partners and whe-
ther women found it difficult or inconvenient to use gel as
only four of these women proceeded to inform their partners
(p value\0.001). This association remained in the multi-
variate model at week 52, without substantially changing
the other associations (AOR 0.08 95 % CI 0.02, 0.27).
Table 2 Individual
characteristics of women who
discussed gel use with their
partner compared to women
who did not discuss gel use at
week 4
a t test
b Three missing values
Characteristics N (%) (col %) Not discussed
N (row %)
Discussed
N (row %)
v2 p value
1092 (100 %) 441 (40 %) 651 (60 %)
Age
18–24 year olds 309 (28 %) 110 (36 %) 199 (64 %) 0.058
25–34 year olds 224 (21 %) 85 (38 %) 139 (62 %)
35–44 year olds 265 (24 %) 111 (42 %) 154 (58 %)
45? year olds 294 (27 %) 135 (46 %) 159 (54 %)
Mean age (SD)a 35.0 (11.65) 36.2 (11.49) 34.2 (11.70) 0.007
Educational level
Primary or lower 535 (49 %) 228 (43 %) 307 (57 %) 0.141
Secondary or higher 557 (51 %) 213 (38 %) 344 (62 %)
Employment status
Employed 184 (17 %) 81 (44 %) 103 (56 %) 0.270
Unemployed 908 (83 %) 360 (40 %) 548 (60 %)
Head of household
Partner 472 (43 %) 208 (44 %) 264 (56 %) 0.090
Parent/in-law 391 (36 %) 142 (36 %) 249 (64 %)
Self 116 (11 %) 50 (43 %) 66 (57 %)
Other 113 (10 %) 41 (36 %) 72 (64 %)
Area of residency
Rural 857 (78 %) 353 (41 %) 504 (59 %) 0.300
Peri-urban/urban 235 (22 %) 88 (37 %) 147 (63 %)
Religion
Zionist 507 (46 %) 202 (40 %) 305 (60 %) 0.882
Shembe 238 (22 %) 104 (39 %) 161 (61 %)
Christian-mainstream 265 (24 %) 101 (42 %) 137 (58 %)
Other 82 (8 %) 34 (42 %) 48 (58 %)
Clinic of enrolment
Clinic 1—township 419 (39 %) 191 (46 %) 228 (54 %) 0.019
Clinic 2—town 353 (32 %) 128 (36 %) 225 (64 %)
Clinic 3—tribal authority 320 (29 %) 122 (38 %) 198 (62 %)
Previous MDP participationb
No 1040 (95.5 %) 425 (41 %) 615 (59 %) 0.086
Yes 49 (4.5 %) 14 (29 %) 35 (71 %)
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Table 3 Socio-economic
characteristics of women who
discussed gel use with their
partner compared to women
who did not discuss gel use at
week 4
Characteristics N (%) (col %) Not discussed N (row %) Discussed N (row %) v2 p value
1092 (100 %) 441 (40 %) 651 (60 %)
Water source
Inside house/yard 333 (30 %) 127 (38 %) 206 (62 %) 0.026
Community source 599 (55 %) 234 (39 %) 365 (61 %)
Free flowing 160 (15 %) 80 (50 %) 80 (50 %)
Fuel for cooking
Electricity 364 (33 %) 143 (39 %) 221 (34 %) 0.856
Gas 88 (8 %) 39 (44 %) 49 (56 %)
Paraffin 139 (13 %) 57 (41 %) 82 (59 %)
Wood 501 (46 %) 202 (40 %) 299 (60 %)
Household ownership (yes)
Cattle 298 (27 %) 137 (46 %) 161 (54 %) 0.021
Electricity 542 (50 %) 206 (38 %) 336 (62 %) 0.112
Radio 954 (87 %) 385 (40 %) 569 (60 %) 0.960
Television 473 (43 %) 182 (38 %) 291 (62 %) 0.262
Telephone 973 (89 %) 387 (40 %) 586 (60 %) 0.240
Fridge 569 (52 %) 219 (38 %) 350 (62 %) 0.183
Bicycle 181 (17 %) 68 (38 %) 113 (62 %) 0.398
Table 4 Sexual behaviour
characteristics of women who
discussed gel use with their
partner compared to women
who did not discuss gel use at
week 4
Characteristics N (col %) Not Discussed
N (row %)
Discussed N
(row %)
v2 p value
1092 (100 %) 441 (40 %) 651 (60 %)
Contraceptive use at week 4
No 403 (37 %) 180 (45 %) 223 (55 %) 0.027
Yes 689 (63 %) 261 (38 %) 428 (62 %)
Average sex in last week
3 or less 502 (46 %) 217 (43 %) 285 (57 %) 0.066
4–6 316 (29 %) 129 (41 %) 187 (59 %)
7 or more 274 (25 %) 95 (35 %) 179 (65 %)
Condom use in last week/4 weeks
Always 581 (53 %) 221 (38 %) 360 (62 %) 0.092
Never/sometimes 511 (47 %) 220 (43 %) 291 (57 %)
Gel use in last week/4 weeks
Always 1065 (98 %) 428 (40 %) 637 (60 %) 0.405
Never/sometimes 27 (2 %) 13 (48 %) 14 (52 %)
Gel group
0.5 % 388 (36 %) 148 (38 %) 240 (62 %) 0.361
2 % PRO 2000 325 (30 %) 141 (43 %) 184 (57 %)
Placebo 379 (35 %) 152 (40 %) 227 (60 %)
Impact on sexual pleasure
Increased 813 (74 %) 336 (41 %) 477 (59 %) 0.278
Same/less 279 (26 %) 105 (38 %) 174 (62 %)
AIDS Behav (2015) 19:832–846 837
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Qualitative Analysis
Four main themes emerged from the qualitative data:
socio-cultural norms of sexual communication, expecta-
tions regarding communication about microbicides,
women’s experiences of discussing microbicides with their
partners, and attitudes and experiences of using microbi-
cides without a partner’s knowledge. We present findings
from each of these themes below.
Sexual Communication
All respondents in the community FGDs and most of the
women in the IDIs had a shared understanding of the tra-
ditional norms regarding sexual communication. Within
this traditional context, women were not supposed to talk
about sex, initiate sex, or even refuse to have sex with their
partner. However, there was a palpable schism in opinion
about how these traditional norms informed contemporary
sexual communication. Approximately half the FGD
respondents and about a quarter of IDI respondents,
believed that these traditional norms still dominated, while
the rest believed that the advent of HIV had altered social
expectations regarding sexual communication. The differ-
ences were predominately gendered and generational, with
most women and younger men believing that communica-
tion norms in relationships had changed or were changing.
These shifting expectations were evident in narratives in
both the FGDs and IDIs. There was a tension between
different expectations regarding the role of women as both
submissive and independent. These contradictory expec-
tations appeared to be informed by traditional images of
women obeying their husbands, and nationalist images of
independent women, which exalt women’s empowerment
and promote women’s rights.
Nonetheless, the overwhelming sentiment from the
FGDs and IDIs was that in contemporary KwaZulu-Natal,
both women and men must break with tradition and talk
about sex in response to the HIV epidemic, as this young
woman explains:
‘There should be no secrets… It’s not like the olden
days. Tell him that there’s something I have found
and I will be using it to protect ourselves because no-
one wants to die, everybody wants to live, no-one
wants to be HIV positive’ (Community FGD, 24 year
old woman).
There were risks involved for women who discussed
sex. For merely initiating communication about sex,
women talked about the risk of abandonment, mistrust,
financial marginalisation, verbal conflict or even physical
abuse.
Expectations Regarding Communication About
Microbicides
The vast majority of FGD respondents and more than three
quarters of the IDI participants believed that women should
discuss gel use with their partners before using it. How-
ever, this apparently simplistic statement was not without
its complexity, as this quote illustrates:
‘It is important to tell (ukutshela) your partner about
the things that you do but only if you know that your
partner will agree with you’ (Trial IDI, 38 year old
woman) (emphasis added).
Similarly, there were a number of examples in the IDIs
where women clearly drew on particular scripts of expec-
ted behaviour depending on what they wanted to do. For
example, if they wanted to tell their partner about the gel
they claimed that culturally they were supposed to talk
about sex; alternatively if they did not want to tell their
partners about the gel they claimed that culturally they
were not supposed to talk about sex. Women at times used
these scripts of expected behaviour interchangeably,
assigning different priorities to often competing expecta-
tions of behaviour depending on the topic.
In the FGDs and IDIs there were different expectations
about the form that the discussion about microbicides
should take which implied different expectations regarding
the decision making process and the role of the male
partner. In the FGDs, the main isiZulu words used in this
context were imvume, cela, xoxa, tshela and azisa. Imvume
means ‘permission’ and was used in the context of women
asking men for permission to use the gel with men being
the ultimate decision makers about whether or not women
could use gel. Cela means to ‘ask’ or ‘negotiate’, xoxa
means to ‘talk’ or ‘tell someone’ about something, tshela
Table 5 Multivariate model comparing women who discussed gel
use with their partner to women who did not discuss gel use at week 4
Adjusted odds ratio (95 % CI) p value
Age (mean) 0.98 (0.97, 0.99) 0.006
Clinic of enrolment
Clinic 1 1.00
Clinic 2 1.54 (1.14, 2,07) 0.005
Clinic 3 1.32 (0.97, 1.80) 0.076
Water source
Inside house/yard 1.00
Community source 1.01 (0.76, 1.36) 0.925
Free flowing 0.70 (0.48, 1.03) 0.074
Household ownership of cattle
No 1.00
Yes 0.72 (0.55, 0.95) 0.021
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means to ‘tell’ or ‘narrate’ or ‘give an account’ of some-
thing, and azisa means to ‘inform’ but was also used in
relation to convincing someone of something. Cela, xoxa,
tshela and azisa all had an inference of negotiation in the
process of seeking agreement.
However, a few mainly younger women used either
tshela or azisa in the sense of literally telling or informing
the partner without any expectation of a negotiation or any
requirement for permission or consent. In these rarer
examples, women were viewed as the ultimate decision
makers about whether or not to use gel. The following
quote illustrates this perspective but is unusual in coming
from a married instead of an unmarried woman:
‘I think I must discuss (ngiphumele obala – speak out
or pronounce) so that he will know that I am using
this thing (gel). This is my life not his life, I can tell
(ngingamtshela) him that there is something that I am
using like this and this, I am protecting myself from
the diseases because you are not faithful, I do not
know the places you go, you cannot trust a person
these days. I can tell (ngimtshele) him that I am using
this thing father (husband) with my life, the life is
mine’ (Community FGD, 44 year old woman).
In the IDIs, women most frequently used the word tshela
to describe their own discussions about the gel with their
partners. In addition, woman in the IDIs sometimes used
the word chaza meaning to explain. The use of this word is
understandable in the IDIs, although it never emerged in
the FGDs, as women in the trial were describing how they
‘explained’ the gel within the context of the clinical trial.
Throughout the IDIs, there was a sense that the whole
discussion hinged on the woman ‘knowing’ her partner and
being able to guess his response well enough to find the
right words, use the right strategy, at the right time, as this
quote demonstrates:
‘A person knows her partner and how he reacts if he
is told something’ (Trial IDI, 28 year old woman).
Women’s Experiences of Discussing Microbicides
Of the 79 women interviewed at week 4, 56 had talked to
their partners about the gel. There were different reasons
for talking about the gel, different ways of talking about it,
and discussions took place at different times in the process
of introducing gel into the relationship.
Reasons for Talking About Gel Women offered two
main reasons for discussing the gel with their partners. The
first reason was that the couple usually discussed sex and
the women felt that as the gel would be present during sex,
men should be aware of it. The majority of the women
interviewed were in long-term stable relationships. Many
of the women described these as loving relationships in
which they trusted each other and did not have secrets from
each other, as stated by this woman:
‘We don’t hide things from each other, he also
doesn’t hide anything from me. We usually discuss
things before doing them’ (Trial IDI, 22 year old
woman).
The second reason, which often overlapped with the first
reason, was to avoid conflict if the partner found out about
the gel. The concerns they expressed included whether the
partner noticed the gel during sex; found the applicators;
heard about the gel and suspected his partner was using it;
if he had penile problems; or if the gel was found to have
safety concerns. Women were also concerned that if their
partner felt a difference during sex they may assume the
woman was having sex with someone else, which is based
on a commonly held myth that men can physically tell
during sex if the woman has had sex beforehand.
Ways of Talking About gel Discussion about the use of
microbicides took place in different ways. In the majority
of cases, women introduced the microbicide study to their
partners and then discussed and negotiated the use of the
gel. A few women explained that they were with their
partners when they first heard about the microbicide study
and this triggered the discussion about the potential of the
woman joining the study. A few other women described
how they simply told their partners about the microbicide
study and men accepted their decision to use gel.
The strategies employed by women to discuss the gel
with their partners largely depended on the decision-
making roles in the relationships. In some examples, it
was clear that the ultimate decision of whether or not to
use the gel rested with the man. In these cases woman
described how they had to convince, cajole and plead
with their partners in order to use the gel. In the vast
majority of cases, the decision-making was based on a
process of negotiation with the aim of reaching joint
agreement. In some cases, the decision-making process
was on going and involved continuous dialogue, as this
quote demonstrates:
‘The first time that I heard from my friends about the
study, I sat down with him, talked to him about it, and
then he allowed me. Even by the time I came back
from the clinic, I as well sat down and informed him
about what had been said. I also told him about the
gel that there is a preventative thing that they have
also given us at the clinic which is in a form of a gel
and he asked how it is being used. I then told him. He
then said, can I please demonstrate for him how is it
being done, I then did as taught, I demonstrated for
him’ (Trial IDI, 29 year old woman).
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There were other cases where men only provided non-
verbal cues. For example, some women talked about the
fact that their male partner walked away during the con-
versation, in which case the woman would assume he was
not particularly happy about the gel but was not going to
object to her using it. In other cases, women read men’s
silence and lack of objection as acceptance of the gel.
Throughout most of the narratives, it was evident that
women firstly decided whether they wanted to use the gel,
then opened up discussions with their partners. This
appeared to shift the balance of decision-making in the
women’s favour.
Less than a quarter of women viewed the decision to use
the gel as theirs alone. However, some were willing to state
this independence of decision making even when faced
with culturally loaded questions, as the exchange below
shows:
Interviewer: ‘Does your partner allow (uyakuvumela)
you to insert gel?’
Participant: ‘I insert gel on my own, not because my
partner allows (engivumela) me to insert’ (Trial IDI,
40 year old woman).
In a few cases, women negotiated their participation in
the study with their partner on the basis of only partial
information. For example, a few women told their partners
they had joined a research study but did not tell them
anything about the gel. Other women told their partners
that they were using a vaginal gel, although they did not
tell them that it was intended as a HIV prevention method.
Instead, the gels were described as preventing other sexu-
ally transmitted infections, as treatment for vaginal prob-
lems, or to prevent cervical cancer. It appeared that by
providing partial information, women felt that they could
claim they had tried to explain the gel if their partners
subsequently challenged them about it. The main reason for
only providing partial information appeared to be to avoid
having to discuss HIV, which was tied up with issues of
trust and fidelity.
Timing of Talking About Gel The majority of women
who discussed the gel with their partners did so after first
learning about the trial at a study screening visit, but before
enrolling in the trial. However, about a fifth of women who
discussed gel use with partners did so after enrolling in the
trial. In some of these cases it appeared that women only
wanted to enter into negotiations with their partners after
deciding for themselves whether they wanted to join the
study and use the gel. While the women who delayed
enrolment until after talking to their partner’s may reflect
more traditional gendered decision-making roles, women’s
decision to discuss gel with their partners only after
enrolling in the trial provides another example of the
decision-making being shifted to women’s advantage.
About a sixth of other women initially used the gel without
discussing it with their partners at all and only told them
about it when they found study material or noticed a dif-
ference during sex.
Although the majority of women told their partners that
they were using the gel, few referred to its use every time
they had sex. There were three main ways in which gel
insertion was managed before sex: (1) the majority of
women inserted the gel discretely before sex without tell-
ing their partner; (2) a smaller group of women overtly told
their partner they were going to insert the gel when pas-
sions were roused. Some of these women interpreted their
partner’s willingness to wait for them to insert as an act of
support. Only a very few women actually inserted the gel
in front of their partners and only one woman talked about
her partner inserting the gel for her; and (3) a small group
of women described how their partners would remind them
to insert the gel as a hint for sex, as this quote shows:
‘If he wants sex he just says ‘’’gel’’, or, ‘‘are we tick-
ing’’ (ticking refers to ticking the coital diary), I know
that it is time for sex, so… he has found the easy way to
ask for sex’ (Trial IDI, 34 year old woman).
In this way, women described the gel as encouraging
communication about sex, which often opened up oppor-
tunities for other discussions, for example about condom
use. There were numerous examples of women stating that
talking about sex and the gel with their husband was more
difficult than with an unmarried partner, and that it was
especially difficult for women to use the gel without talking
to their partner if they were living together.
Use of Microbicides Without a Partner’s Knowledge
Although everyone in the FGDs agreed that ideally male
partners should know about the gel before it is used, a
minority of women and younger male respondents thought
that women could be justified in using the gel without their
partner’s knowledge in some circumstances. One example
was if a woman had experience of her partner refusing
specific requests previously. In these circumstances, some
women believed that women should use the gel without
telling their partner:
‘You do not do something without asking him, you
know your partner. You firstly ask him that can I use
this or can we use this. If you see that he is not
allowing it, you just keep quiet and continue using it
secretly’ (Community FGD, 41 year old woman).
Other examples of when use without a partner’s
knowledge was justified were if he was HIV positive, had
other partners, refused to use condoms, or was frequently
drunk, thereby unreliable in terms of condom use. The
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sense in these examples was that if men failed to be what
would traditionally be considered a good and reliable
husband, then his partner had the right to breach traditional
norms in response to his failings as a husband. In these
circumstances, the respondents commented that if the
woman was caught using the gel secretly, then she would
have to tell her partner the truth. However, they all agreed
that this could lead to accusations of infidelity and would
cause conflict in the relationship.
After 4 weeks in the trial, 23 of the 79 trial participants
interviewed had not discussed their use of the microbicide
gel with their partner. All but one of these women had at
least one subsequent interview, and by their last interview,
15 had still not discussed gel with their partner (4 at week
24 and 11 at week 52). When talking about using gel
without their partner’s knowledge, women mainly referred
to using it secretly (imfihlo) or hiding it (fihla) and
described how it was only theirs (not their partners) as in
the description of ‘kuphela ukwazi kwami’, mine alone.
Four main reasons for women using the gel without
telling their partner emerged from the data. Firstly, most of
the women still thought it was preferable to discuss gel
with their partner and hoped to do so some time in the
future but had not yet found the right time. However, of the
seven women who subsequently told their partners about
the microbicide gel, half only did so after the partner found
the applicators or noticed the gel during sex. Secondly,
some of the women, mainly young and unmarried, did not
think that it was important to discuss the gel with their
partners and had no intention of doing so. Thirdly, some
women did not want to risk talking to their partners about
the gel as they assumed that they would object. This young
woman illustrates that by not living in her partner’s house
(not being married or cohabitating) she felt she had more
ability to decide about the gel:
‘I think he will have a problem, maybe say I should
stop the gel, so I thought it is better to continue and
hide it from him. He cannot control me because it is
my home’ (Trial IDI, 29 year old woman).
Fourthly, about half a dozen women explained that they
had not discussed the gel with their partners because they
were afraid that they would take their use of gel as a sign of
mistrust and respond violently:
‘He doesn’t know about the gel and I don’t want him
to know because he is jealous and if he finds out he
will beat me. I can’t just talk, I’m afraid of him’
(Trial IDI, 21 year old woman).
Most of the women who were still using gel without
their partner’s knowledge after about a month in the study
were concerned in case their partners found out about the
gel before they had chance to discuss it. However, a few
had decided that it was a risk they were willing to take.
Using the gel without the knowledge of a stable partner
was not viewed as the ideal, but importantly was viewed as
possible in some circumstances.
We did not systematically ask women if they would use
the gel regardless of their partner’s response. However, of
the women who discussed the gel with their partners,
approximately a tenth spontaneously reported they would
not have used the gel if their partners had objected. An
equal number spontaneously reported the opposite, that
they would have used the gel even if their partners had
objected.
Most women were able to describe strategies that they
used to insert the gel before sex, such as going to the toilet
to insert the gel if passions were roused. However, it was
evident in some women’s accounts that it was more diffi-
cult to use the gel when partners were unaware of it, and
that inserting additional applicators of gel between sex acts
could be particularly difficult.
Only a few women in the IDIs admitted having sec-
ondary casual partners and in the main, they had not talked
to these partners about the gel. There was no suggestion in
the qualitative data that women who did not use condoms
were more likely to use the gel without their partner’s
knowledge.
Discussion
In this study, conducted among women enrolled in a micro-
bicide trial in KwaZulu-Natal, more than half the women
(60 %) had discussed gel use with their partner by the fourth
week of the trial, and the majority (84 %) had discussed gel
use by the end of their time in the trial. Our findings, consistent
with other evidence, showed that in contemporary KwaZulu-
Natal, socio-cultural norms regarding sexual communication
are changing in response to the magnitude of the HIV epi-
demic and the national discourse of women’s rights and
gender equality [48, 49]. It is clear from this study, that both
traditional gender norms as well as modern ideas of women’s
rights inform expectations of communication about microbi-
cides. Women in committed relationships were expected to
discuss the use ofmicrobicides with their partners andwomen
clearly preferred to use microbicides with their partner’s
knowledge. However, there was tolerance for the use of mi-
crobicides without a partner’s knowledge in some circum-
stances, although the women who used microbicides without
their partner’s knowledge appeared to be women least able to
discuss microbicides with their partners. Using gel without a
partner’s knowledge negatively affected consistent gel
adherence over the course of the trial.
From the quantitative data at week 4, older women were
less likely to discuss microbicides with their partners than
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younger women. This may be explained by the idea
expressed in the qualitative interviews that traditional
views regarding women not being able to talk about sex
still prevail. It is possible that older women’s ability to
discuss microbicides was limited by the influence of more
traditional views among older couples. The qualitative data
suggests that the majority of women who had not discussed
microbicides with their partners by week 4, still hoped to
do so, and many subsequently did. Most women had dis-
cussed the use of microbicides by the end of their time in
the study and there were no longer any age differences
between women who had and had not. As such, the
quantitative and qualitative data suggest that older women
may be less able to discuss microbicides with their partners
initially, but ultimately most find the appropriate time to
raise the topic. Although quantitatively younger women
were more likely to have discussed the gel with their
partners, in the IDIs, the women who expressed no inten-
tion or need to discuss gel use with their partners were
mainly younger women. These findings highlight the need
for microbicide introduction messages to be sensitive to the
different needs of younger and older women. Although
there is no comparable evidence from microbicide trials, a
study in South Africa and Zimbabwe found that older
women were less likely to discuss the use of a diaphragm
with their partners than younger women [50].
Women who lived in households that relied on free
flowing water and owned cattle were also less likely to
discuss microbicides with their partners. The significance
of water source diminished in the multivariate model at
week 4 but remained at week 52, whereas the association
with owning cattle was found at both weeks 4 and 52.
Water source and household assets were included in this
analysis as socio-economic determinants. However, the
qualitative data hint at an alternative interpretation of the
relevance of these variables suggesting that in addition to
indicating household wealth, they may also indicate tradi-
tional status. Cattle are the most important symbol of status
in Zulu culture and are the basis of marital arrangements
[51]. While the use of free flowing water is usually an
indicator of lower socio-economic status, in this area it also
suggests that the household is particularly remote [52]. On
the basis of the discussions about traditional versus modern
views about communication, we could speculate that cattle
ownership and the use of free flowing water, in this ana-
lysis, are signs of more traditional households in which it is
more difficult for women to talk about microbicides.
At week 4, we measured gel adherence in the last week
based purely on self-reported usage, which in known to be
subject to social-desirability bias [41]. After only four
weeks of using gel, adherence was not associated with
whether a woman had discussed the gel with her partner or
not. However, over the course of the trial we used a longer-
term measure of adherence, which was based on self-
reported use at multiple time points, clinic attendance, and
the return of used applicators. By the end of the trial,
women who had discussed gel with their partners were
50 % more likely to have consistently used gel than women
who had not. This is a striking and important difference,
which confirms the assumption that using the gel without a
partner’s knowledge may hinder adherence for some
women [20, 53]. The qualitative results also support this
finding by highlighting that it was more difficult for some
women to use gel without their partner’s knowledge,
especially between sex acts. However, it is important to
note that although the longitudinal measure of adherence
provided a more complete picture of women’s non-use of
gel than cross sectional measures, it was still constrained
by relying on self-reported or proxy measures and may
well over estimate true adherence. It will be important to
explore the association between women’s communication
with their partner’s and usage using objective measures of
adherence in future trials.
This study reflects microbicide communication between
stable couples, many of which in in-depth interviews
described their relationships as loving and trusting, and as
such is likely to be substantially different from women in
less stable unions. However, among women in stable
relationships, the qualitative findings suggest that it would
be more difficult for women to use microbicides without
their partner’s knowledge if they were married or living
together. There were no differences in the proportion of
women who discussed microbicides with their partners
based on their relationship to the head of the household,
although we were not able to control for marital status or
cohabitation with a partner in the quantitative analysis. Not
cohabitating has been shown to be associated with using a
diaphragm without a partner’s knowledge [54].
The quantitative data showed that the proportion of
women who discussed microbicides with their partners
differed between the clinics at week 4, but not by the end of
the trial. Although the counselling scripts were supposed to
be standardised, this difference appears to be related to
specific counsellors. This may reflect the individual opin-
ions of counsellors or differing levels of competency in
counselling. The impact of counselling on women’s deci-
sion to discuss microbicides with their partners has not
been measured previously in microbicide or diaphragm
trials. This finding suggests that the counselling process is
likely to influence women’s decision or ability to discuss
microbicides with their partners. The qualitative data
showed that women were creative in their approaches to
discussing microbicides, providing as much or as little
information as they felt was warranted depending on their
knowledge of their partners character. The use of partial
information was also reported by women negotiating the
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use of diaphragms [54]. The impact on adherence of a
partner knowing about the microbicide, the importance of
counselling on women’s ability to discuss microbicides,
and the diversity of strategies that women employ to dis-
cuss microbicides, highlight the need for more focus on the
development and evaluation of counselling messages that
are tailored to women’s individual circumstances. In
acknowledging women’s preference for discussing micro-
bicides with their partners there is increasing focus on the
need to include men in microbicide introduction pro-
grammes [28]. However, as this analysis suggestions, it is
important to ensure that by including men, we don’t
undermine women’s ability to make autonomous decisions
about whether to discuss microbicides with their partners
and to employ creative strategies regarding how to discuss
them.
By the end of the trial, women differed in terms of
whether they had discussed microbicides with their part-
ners depending on the type of gel they had been allocated
to use. There is no indication in this study or any other
MDP analysis that women preferred any one of the three
gels used in the trial [45, 55]. The majority of women
assigned to 2 % PRO2000 gel stopped using the gel before
the end of their year follow up period due to the closure of
this gel arm, and therefore would have had less time to
discuss the gel with their partners. However, this is not a
sufficient explanation, as it does not explain the difference
for the placebo group. As such, it is not clear why women
assigned to the 2 % PRO2000 or placebo gel groups would
be less inclined to talk to their partners about the gel than
women given 0.5 % PRO2000 in this blinded trial. One of
the few studies to have reported on women’s communi-
cation by gel type, compared three different formulations
of N-9 and found no correlation between women’s pref-
erences for formulations and discussing the product with
their partners [5].
To date, the later stage microbicide effectiveness trials
have not reported on the extent to which women discuss
microbicide gels with their partners. A diaphragm trial
found that 15 % and 19 % of women in Durban and
Johannesburg respectively used the diaphragm without
their partner’s knowledge for up to 2 years, compared to
only 1 % of women in Zimbabwe. The authors concluded
that ‘women in South Africa seemed to emphasize indi-
vidual rights and personal agency to justify covert use as
compared to women from Zimbabwe, who made a stronger
case about negative consequences if caught’ (54;1552).
This conclusion infers a link between women’s agency and
diaphragm use without a partner’s knowledge. Our findings
add additional nuance to this debate of whether it is
women’s personal agency or lack thereof, which would
encourage women to use a microbicide or diaphragm
secretly. On the one hand, the qualitative data, especially
from the IDIs with trial participants, suggest that the
growing national discourse that women have a right to
protect themselves from HIV is viewed as justification to
use microbicides without a partner’s knowledge. On the
other hand, the quantitative and qualitative findings suggest
that women who used the gel without their partner’s
knowledge were the ones who felt least able to discuss
microbicides with their partners. As such, in this predom-
inantly rural area of KwaZulu-Natal it is not clear the
extent to which women’s agency increases women’s ability
to discuss microbicides with their partner or use microbi-
cides without their knowledge. The qualitative data sug-
gests that women’s decision about if, when and how to
discuss microbicides with their partners is influenced by
the gendered decision-making roles in the relationship. The
importance of gender-norms and decision-making roles for
HIV prevention [56–59] and microbicide acceptability is
well recognised [28, 31, 60], although rarely measured in
microbicide trials. In terms of supporting women to use
microbicides in the future, we need to further explore
women’s decisions of whether or not to discuss microbi-
cides with their partners, and the role that gender-norms
and decision-making roles play in this decision. It is
however also important to note, that the ways in which
women reported if, when and how they communicated with
their partners about microbicides, could also be influenced
by social-desirability and the dichotomous discourse of the
role of traditional verses modern women in South Africa.
In addition to exploring how decision-making roles
influence women’s discussion about microbicides with
their partners, it will be equally important to assess how the
availability of microbicides influences decision-making
roles within couples. The qualitative data provided a
number of examples whereby decision-making power was
shifted in the women’s favour by the fact that these were
female-used products. The most important factor, as seen
with diaphragms previously [54], is that unlike with con-
doms, once microbicides have been discussed by a couple,
most women then proceed to use them without needing to
negotiate their use every time they have sex. However,
despite the overarching sentiment that women had the right
to use a microbicide to protect themselves from HIV with
or without a partner’s knowledge, the qualitative data also
demonstrated that the implications of male partner’s find-
ing out about women’s use of microbicides could be con-
siderable. It is evident from these findings that male
partner’s opposition to microbicides and the risks involved
with using microbicides without a partner’s knowledge will
remain a barrier to microbicide access for some women.
Given the high levels of intimate partner violence in South
Africa, messaging around microbicides needs to take
account of the risks inherent in the secret use of microbi-
cides for some women [61].
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In this study, women’s discussions with their partners
about enrolling in the clinical trial and using a microbicide
gel were merged into one conversation. It was impossible
to separate these conversations as for women they were one
and the same. Similarly, in this blinded trial it was
impossible to discern what impact women’s chance of
randomisation to a placebo gel had on the decision to
discuss microbicides. The reasons for discussing microbi-
cides in the future when they are known to prevent HIV
acquisition and are widely available, are likely to be dif-
ferent to the reasons for discussing microbicides in the
context of a placebo-controlled clinical trial. Nonetheless,
these findings provide an important insight into some of the
challenges that women face when discussing microbicides
with their partner and the creativity that women are likely
to employ in their use of microbicides [36, 37].
Conclusion
The women enrolled in this trial, conducted in KwaZulu-
Natal, clearly preferred to use microbicides with their
partner’s knowledge. Changing attitudes to gender rela-
tions that have been influenced by the national discourse on
women’s rights and the HIV epidemic, appear to facilitate
female initiated conversations about sex, and enable
women to talk about microbicides. Traditional ideas of
women’s roles are still prevalent, and inhibit some women
from discussing microbicides with their partner, although
this analysis demonstrates that the majority of women are
successful at negotiating their use or feel justified in using
microbicides without a partner’s knowledge. While there is
tolerance for the use of microbicides without a partner’s
knowledge, and a minority of women succeed in using the
gel secretly, this appears to have a negative impact on long-
term gel adherence. Introductory microbicide programmes
will rely on clear and consistent counselling messages, that
should be tailored to women’s specific circumstances. Our
findings demonstrate that in KwaZulu-Natal the socio-
cultural norms relating to sexual communication are ame-
nable to the introduction of microbicides. The findings also
present yet another example of the important contribution
that microbicides can make in terms of offering women
HIV prevention options that they can both use and control.
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